Skip to content

    Breast Cancer Health Center

    Select An Article

    Breast Cancer and Biological Therapy

    Font Size
    A
    A
    A

    Biological therapy uses the body's own immune system to target and fight breast cancer cells.

    One such antibody is trastuzumab (Herceptin), a monoclonal (meaning single) antibody. An antibody is a protein made by the body's own immune system. Trastuzumab is a manmade antibody that can work only if the woman carries and overexpresses the HER2 protein in those tumor cells. About 25% of breast cancer patients carry this gene and are considered HER2 positive. Your doctor should check this on your breast biopsy or on the tumor removed during surgery.

    Recommended Related to Breast Cancer

    Expert Q&A: Getting the Best Breast Cancer Treatment

    Each year in the United States, close to 250,000 women learn they have breast cancer. As they deal with their diagnosis, they are also asked to make daunting decisions about how to best fight their disease. New patients facing treatment need to understand their options, and that means learning all they can about their cancer, says breast cancer surgeon Lee Gravatt Wilke, MD. Wilke, who is an assistant professor of surgery at Duke University Health System and a board member of the NavigateCancer...

    Read the Expert Q&A: Getting the Best Breast Cancer Treatment article > >

    Trastuzumab is the first-line treatment of HER2-positive metastatic breast cancer in combination with chemotherapy drugs. Trastuzumab may also be used alone, indefinitely, for HER2- positive metastatic breast cancer.

    Pertuzumab (Perjeta) is another monoclonal antibody approved for treatment of HER2-positive metastatic breast cancer or for patients who need neo-adjuvant treatment (treatment before surgery). It is approved for use in combination with trastuzumab and the chemotherapy docetaxel (Taxotere).

    Another drug for patients with HER2 positive disease is lapatinib (Tykerb). It works in HER2-positive patients when trastuzumab is no longer effective. It is used in combination with capecitabine (Xeloda), letrozole (Femara), or trastuzumab.

    Ado-trastuzumab emtansine (Kadcyla) is a drug used in patients who have metastatic disease and have already taken trastuzumab and a class of chemotherapy drugs called taxanes, which are commonly used to treat breast cancer. These drugs may have been used together or separately. 

    Other types of antibodies are being researched to fight cancer and include:

    • Angiogenesis inhibitors. These antibodies prevent the growth of new blood vessels, cutting off the supply of oxygen and nutrients to cancer cells. However, the only such drug used for breast cancer, bevacizumab (Avastin), lost its FDA approval for breastcancer because the drug's risks outweighed its benefits and it didn't improve the overall survival of breast cancer patients.
    • Signal transduction inhibitors. These antibodies block signals inside the cancer cell that helps the cells divide, stopping the cancer from growing. They are currently being studied to see if they're effective.

    Before treatment begins, print out these Questions to Ask to help you better understand your care.

    Also see, Follow-Up Care After Your Treatment.

    Next Article:

    Today on WebMD

    Breast Cancer Overview
    From mammograms to living after treatment.
    Dealing with breast cancer
    Get answers to your questions.
     
    woman having mammogram
    The 3 latest tips to know.
    woman undergoing breast cancer test
    Most abnormalities aren’t breast cancer.
     
    Resolved To Quit Smoking
    VIDEO
    Breast Cancer Treatments Improving
    Article
     
    Woman getting mammogram
    Article
    Screening Tests for Women
    Article
     
    serious woman
    Article
    Pink badge on woman chest to support breat cancer
    QUIZ
     
    what is your cancer risk
    Article
    breast cancer survivors
    Article